Correlation of HbA1c with urinary ACR, serum creatinine and eGFR in type-2 diabetes mellitus at Puducherry, South India

Vithiavathi Sivasubramanian, Karthik Jetty, S. Senthil Kumar


Background: Diabetes Mellitus (DM) is a major emerging clinical health problem in this world. Anemia is a common problem in diabetes. Type 2 DM comprises about 90% of diabetic population of any country.

Methods: A cross-sectional study carried out among 125 type 2 diabetic mellitus patients’ area at Department of Medicine Aarupadai Veedu Medical college (AVMC) and hospital, Puducherry during the period from May 2018 to October 2018.The objectives of the study were to evaluate the association of HbA1c with urinary ACR, eGFR and serum creatinine in Type 2 diabetes mellitus. Data was analyzed using the SPSS version 20.0 software.

Results: The randomly selected study group comprised 100 type 2 DM patients and 25 control peoples of 35-70 years of age. Type 2 DM patients were evaluated of HbA1c, normotensives or hypertensives. FBS, serum creatinine, urinary albumin and creatinine were estimated. Urinary ACR and eGFR and were calculated. The data result was expressed as mean and standard deviation. A probability value is less than 0.05 and it was considered statistically significant.

Conclusions: Type 2 diabetes mellitus patients, HbA1c and duration of diabetes were the strongest predictors of micro albuminuria and age was the strongest predictors of a low eGFR. The diabetes was poorly controlled, making the progression to end stage renal failure in concern patients. They measure the prevention of urinary albumin excretion, development of renal abrasion, smoking termination, strict glycaemic control and initiating lipid lowering therapy.


eGFR, HbA1c, Type 2 diabetes mellitus, Urinary ACR

Full Text:



Fayed FM, Elsaied ARA, Mohammed AA, Moubark IA. Proportion of anemia in type 2 diabetic patients in qena governorate case-control study: clinical correlates and prognostic significance. Int J Dia Res. 2013;2(4):64-75.

Frier M, Fisher BM. Diabetes mellitus. In: Colledge NR, Walker BR, Ralston SH, eds. Davidson’s principles and practice of medicine. 21st ed. Printed in China: Churchil Livingstone. 2010: 793-830.

Nazmin H, Bidhan CD, Mohammad I, Khondaker S, Monojit M, Shahadat H. Association of HbA1c with urinary ACR and eGFR in type-2 diabetes mellitus. Pulse. 2011;5(1):6-11.

Barnett PS, Braunstein GD. Diabetes mellitus. In: Carpenter CCJ, Griggs RC, Losclzo J, editors. Cecil’s essentials of medicine. 6th ed. Philadelphia: Saunders. 2004:621-638.

Van Dijk C, Berl T. Pathogenesis of diabetic nephropathy. Rev Endocr Metab Disord. 2004;5:237-48.

Locatelli F, Canaud B, Eckardt KU. The importance of diabetic nephropathy in current nephrological practice. Nephrol Dial Transplant. 2003;18:1716-25.

Damsgaard, EM, Froland A, Jorgensen OD, Mogensen CE. Microalbuminuria as predictor of increased mortality in elderly people. BMJ. 1990;300:297-300.

Bhupesh M, Sumit KT, Maheep S, Bushra F. Association of C-reactive protein with renal functions and microalbuminuria in type 2 diabetes mellitus. IOSR J Dental Med Sci. 2018;17(9):79-84.

Sobngwi E, Mauvais-Jarvis F, Vexiau P. Diabetes in Africans. Part 1: Epidemiology and clinical specificities. Diab Metab. 2001;27:628-34.

Mbanya JC, Sobngwi E. Diabetes in Africa. Diabetes microvascular and macrovascular disease in Africa. J Cardiovasc Risk. 2003;10:97-102.

Levitt NS. Diabetes in Africa: epidemiology, management and healthcare challenges. Heart. 2008;94:1376-82.

Guariguata L, Nolan T, Beagley J. IDF Diabetes Atlas. 6th ed: International Diabetes Federation. 2013:12-3.

Sato F, Tamura Y, Watada H, Kumashiro N, Igarashi Y. Effects of diet- induced moderate weight reduction on intrahepatic and intramyocellular triglycerides and glucose metabolism in obese subjects. J Clinic Endocrino Metabol. 2007;92(8): 3326-29.

U.S. Renal Data System: USRDS 2008 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, MD: National institute of diabetes and digestive and kidney diseases; 2008:1-12.

Nosadini R, Tonolo G. Blood glucose and lipid control as risk factors in the progression of renal damage in type 2 diabetes. J Nephrol. 2003;16: S42-7.

Thomas L. Clinical laboratory diagnostics. 1st ed. Frankfurt: TH-Books Varlagsgesells Chaft. 1998:374-77,

American diabetes association. Standards of medical care for patients with diabetes mellitus. Diab Care. 2001;24 (1):33-4.

Bakker AJ, Mucke M. Gammopathy interference in clinical chemistry assays: mechanisms, detection and prevention. Clin Chem Lab Med. 2007;45(9): 1240-3.

Young DS. Effects of drugs on clinical laboratory tests. 5th ed. Washington, DC: The American association for clinical chemistry. 2000:579-581.

CLSI. Evaluation of precision performance of quantitative measurement methods; approved Guideline- Second edition. CLSI document EP5-A2. USA. 2008:5-12.

Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med. 1999;130(6): 461-70.

Venugopal S, Layer UM. Risk factor analysis and prevalence of microalbuminuria among type 2DM subjects: the need for screening and monitoring microalbumin. Asian J Exp Biol Sci. 2010;1(3): 652-59.

Haque N, Debnath BC, Ibrahim M, Sirajuddin K, Majumder M, Hossain M S. Association of HbA1c with Urinary ACR and eGFR in type-2 diabetes mellitus. Pulse. 2011;5:6-11.

Sheik S, Beig JA, Iqbal T, Kazmi T. Prevalence of microalbumineria with relation to glycemic control in T2 diabetic patients in Karachi. J Ayub Med Coll. Abbottabad. 2009;21(3):83-6.

Zachary T, Bloomgarden. Diabetic Nephro. Diabetes Care. 2005; 28(3)745-51.